Carnitine palmitoyltransferase (CPT) deficiencies

The carnitine palmitoyltransferase deficiencies are the two inherited defects of the carnitine shuttle's transferase steps: CPT1A deficiency, which blocks formation of long-chain acylcarnitines at the outer mitochondrial membrane, and CPT II deficiency, which blocks their reconversion to acyl-CoAs at the inner membrane. Both cut off mitochondrial long-chain fatty acid beta-oxidation and therefore fail the same physiological stress test - fasting, intercurrent illness, or prolonged exercise, when tissues must switch to fat as fuel - but they sit on opposite sides of the shuttle and leave opposite acylcarnitine signatures.

Why this grouping

Grouped on the shared mechanism (loss of a carnitine palmitoyltransferase step of the carnitine shuttle, cutting off long-chain fatty acid beta-oxidation) and on the paralogous gene family that names the group. The members are deliberately kept as separate Disease entries because the two blocks are biochemically and clinically distinct: CPT1A deficiency presents as hypoketotic hypoglycemic hepatic encephalopathy of infancy with elevated free carnitine and low long-chain acylcarnitines, and has no myopathic form; CPT II deficiency accumulates long-chain acylcarnitines and spans three forms, including the common adult myopathic form with exercise-induced rhabdomyolysis - a presentation CPT1A deficiency does not produce. The newborn-screening flags run in opposite directions (high C0 with low C16/C18 species versus elevated C16/C18:1/C18:2 acylcarnitines), so merging the two entries would blur exactly the biochemistry that distinguishes them at diagnosis. Boundary notes: the neuronal paralog CPT1C is excluded - its variants cause a hereditary spastic paraplegia (curated separately as CPT1C-Related Hereditary Spastic Paraplegia) with no fatty acid oxidation failure phenotype, so gene-family kinship alone does not admit it. Carnitine-acylcarnitine translocase (SLC25A20) deficiency shares the shuttle and much of the clinical picture but is not a carnitine palmitoyltransferase deficiency; it belongs beside this grouping in any future carnitine-shuttle or long-chain FAO disorder grouping, not inside it.

MONDO alignment & provenance

skos:exactMatch MONDO:0700284 · carnitine palmitoyl transferase deficiency

The grouping concept corresponds exactly to the MONDO carnitine palmitoyl transferase deficiency class, whose descendants are the two members and the clinical forms of CPT II deficiency. CPT1C-related disease is not a descendant of this class, matching its exclusion here.

Membership criteria

NECESSARY  (member ⇒ criteria)
Every member is caused by deficiency of a carnitine palmitoyltransferase of the mitochondrial carnitine shuttle (CPT1A or CPT2), impairing the shuttle and long-chain fatty acid beta-oxidation.

Coverage and gaps

2 rows DisMech coverage of exact MONDO scope: 2/2 (100.0%) 2 listed in scope 0 MONDO gaps

Exact MONDO scope: MONDO:0700284 · carnitine palmitoyl transferase deficiency Completeness is counted over rows inside this exact MONDO scope that are listed in this grouping. Finer MONDO descendants under already-covered DisMech concepts are suppressed (3).

Status DisMech entry MONDO concept In DisMech Has MONDO ID In grouping MONDO Member state Conditions satisfied C1.1 Deficiency of liver-type CPT1 (CPT1A). hgnc:2328 C1.2 Deficiency of CPT II (CPT2). hgnc:2330 C1.3 The carnitine shuttle is impaired. GO:0006853
listed in scope
Carnitine Palmitoyltransferase 1A Deficiency DISEASE
Differentiating mechanism
The block is at the outer mitochondrial membrane, before acylcarnitine formation: long-chain acyl-CoAs cannot be converted to acylcarnitines, so free carnitine is high and long-chain acylcarnitine species are low - the inverse of the CPT II signature. The phenotype is hepatic (fasting-provoked hypoketotic hypoglycemia and hepatic encephalopathy), with a distinctive arctic founder allele (P479L); there is no rhabdomyolysis-dominant adult form. CPT1A hgnc:2328
carnitine palmitoyltransferase 1A deficiency
MONDO:0009705
yes yes yes listed satisfied SATISFIED NOT SATISFIED SATISFIED
listed in scope
Carnitine Palmitoyltransferase II Deficiency DISEASE
Differentiating mechanism
The block is at the inner mitochondrial membrane, after acylcarnitine import: long-chain acylcarnitines accumulate (elevated C16, C18:1, and C18:2 species, high (C16+C18:1)/C2 ratio) and are themselves membrane-toxic. The clinical spectrum spans lethal neonatal and severe infantile hepatocardiomuscular forms through the common adult myopathic form with exercise-, fasting-, or illness-triggered rhabdomyolysis and myoglobinuria - the presentation that most sharply separates it from CPT1A deficiency. CPT2 hgnc:2330
carnitine palmitoyltransferase II deficiency
MONDO:0015515
yes yes yes listed satisfied NOT SATISFIED SATISFIED SATISFIED

Source

View YAML on GitHub
Raw YAML
name: Carnitine Palmitoyltransferase Deficiencies
display_name: Carnitine palmitoyltransferase (CPT) deficiencies
creation_date: "2026-08-28T00:00:00Z"
description: >-
  The carnitine palmitoyltransferase deficiencies are the two inherited
  defects of the carnitine shuttle's transferase steps: CPT1A deficiency,
  which blocks formation of long-chain acylcarnitines at the outer
  mitochondrial membrane, and CPT II deficiency, which blocks their
  reconversion to acyl-CoAs at the inner membrane. Both cut off mitochondrial
  long-chain fatty acid beta-oxidation and therefore fail the same
  physiological stress test - fasting, intercurrent illness, or prolonged
  exercise, when tissues must switch to fat as fuel - but they sit on
  opposite sides of the shuttle and leave opposite acylcarnitine signatures.
grouping_basis:
- SHARED_MECHANISM
- SHARED_GENE_FAMILY
grouping_rationale: >-
  Grouped on the shared mechanism (loss of a carnitine palmitoyltransferase
  step of the carnitine shuttle, cutting off long-chain fatty acid
  beta-oxidation) and on the paralogous gene family that names the group.
  The members are deliberately kept as separate Disease entries because the
  two blocks are biochemically and clinically distinct: CPT1A deficiency
  presents as hypoketotic hypoglycemic hepatic encephalopathy of infancy
  with elevated free carnitine and low long-chain acylcarnitines, and has no
  myopathic form; CPT II deficiency accumulates long-chain acylcarnitines
  and spans three forms, including the common adult myopathic form with
  exercise-induced rhabdomyolysis - a presentation CPT1A deficiency does not
  produce. The newborn-screening flags run in opposite directions (high C0
  with low C16/C18 species versus elevated C16/C18:1/C18:2 acylcarnitines), so
  merging the two entries would blur exactly the biochemistry that
  distinguishes them at diagnosis.

  Boundary notes: the neuronal paralog CPT1C is excluded - its variants
  cause a hereditary spastic paraplegia (curated separately as
  CPT1C-Related Hereditary Spastic Paraplegia) with no fatty acid oxidation
  failure phenotype, so gene-family kinship alone does not admit it.
  Carnitine-acylcarnitine translocase (SLC25A20) deficiency shares the
  shuttle and much of the clinical picture but is not a carnitine
  palmitoyltransferase deficiency; it belongs beside this grouping in any
  future carnitine-shuttle or long-chain FAO disorder grouping, not inside
  it.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0700284
      label: carnitine palmitoyl transferase deficiency
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      The grouping concept corresponds exactly to the MONDO carnitine
      palmitoyl transferase deficiency class, whose descendants are the two
      members and the clinical forms of CPT II deficiency. CPT1C-related
      disease is not a descendant of this class, matching its exclusion
      here.
membership_criteria:
- description: >-
    Every member is caused by deficiency of a carnitine palmitoyltransferase
    of the mitochondrial carnitine shuttle (CPT1A or CPT2), impairing the
    shuttle and long-chain fatty acid beta-oxidation.
  criteria_semantics: NECESSARY
  logic:
    operator: AND
    operands:
    - operator: OR
      description: A carnitine palmitoyltransferase gene is the causal locus.
      operands:
      - criterion_predicate: HAS_GENE
        description: Deficiency of liver-type CPT1 (CPT1A).
        gene:
          preferred_term: CPT1A
          term:
            id: hgnc:2328
            label: CPT1A
      - criterion_predicate: HAS_GENE
        description: Deficiency of CPT II (CPT2).
        gene:
          preferred_term: CPT2
          term:
            id: hgnc:2330
            label: CPT2
    - criterion_predicate: HAS_BIOLOGICAL_PROCESS
      description: The carnitine shuttle is impaired.
      biological_processes:
      - preferred_term: Carnitine shuttle
        term:
          id: GO:0006853
          label: carnitine shuttle
        modifier: DECREASED
members:
- member: Carnitine Palmitoyltransferase 1A Deficiency
  member_type: DISEASE
  display_name: CPT1A deficiency (outer-membrane block)
  differentiating_mechanisms:
  - description: >-
      The block is at the outer mitochondrial membrane, before acylcarnitine
      formation: long-chain acyl-CoAs cannot be converted to acylcarnitines,
      so free carnitine is high and long-chain acylcarnitine species are low
      - the inverse of the CPT II signature. The phenotype is hepatic
      (fasting-provoked hypoketotic hypoglycemia and hepatic
      encephalopathy), with a distinctive arctic founder allele (P479L);
      there is no
      rhabdomyolysis-dominant adult form.
    gene:
      preferred_term: CPT1A
      term:
        id: hgnc:2328
        label: CPT1A
- member: Carnitine Palmitoyltransferase II Deficiency
  member_type: DISEASE
  display_name: CPT II deficiency (inner-membrane block)
  differentiating_mechanisms:
  - description: >-
      The block is at the inner mitochondrial membrane, after acylcarnitine
      import: long-chain acylcarnitines accumulate (elevated C16, C18:1,
      and C18:2 species, high (C16+C18:1)/C2 ratio) and are themselves
      membrane-toxic. The clinical spectrum spans lethal neonatal and
      severe infantile hepatocardiomuscular forms through the common adult
      myopathic form with exercise-, fasting-, or illness-triggered
      rhabdomyolysis and myoglobinuria - the presentation that most sharply
      separates it from CPT1A deficiency.
    gene:
      preferred_term: CPT2
      term:
        id: hgnc:2330
        label: CPT2
notes: >-
  Created from the stub-queue lump/split review: the seeded stub for
  MONDO:0700284 (carnitine palmitoyl transferase deficiency) resolved as
  entry_type GROUPING because both constituent diseases are already curated
  as separate entries and the label names their union - two paralogous
  transferase deficiencies on opposite sides of one shuttle, with opposite
  acylcarnitine signatures. Both members annotate GO:0006853 (carnitine
  shuttle), so the biological-process leaf is machine-checkable.